Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
The journal of nutrition, health & aging
Published in: The journal of nutrition, health & aging 3/2009

01-03-2009 | Critical Evaluation of Self-Rated Quality of Life in Mild Cognitive Impairment and AD

Critical evaluation of self-rated quality of life in mild cognitive impairment and Alzheimer’s disease — Further evidence for the impact of anosognosia and global cognitive impairment

Authors: Martin Berwig, H. Leicht, H. J. Gertz

Published in: The journal of nutrition, health & aging | Issue 3/2009

Login to get access
Metadata
Title
Critical evaluation of self-rated quality of life in mild cognitive impairment and Alzheimer’s disease — Further evidence for the impact of anosognosia and global cognitive impairment
Authors
Martin Berwig
H. Leicht
H. J. Gertz
Publication date
01-03-2009
Publisher
Springer-Verlag
Published in
The journal of nutrition, health & aging / Issue 3/2009
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-009-0063-4

Other articles of this Issue 3/2009

The journal of nutrition, health & aging 3/2009 Go to the issue

Fish Consumption and Cognitive Function Among Older People in the UK

Fish consumption and cognitive function among older people in the UK: Baseline data from the OPAL study

Editorial

CTAD international research conference: Clinical trials in Alzheimer’s disease

Second Generation AD Vaccines

Development of AFFITOPE vaccines for Alzheimer’s disease (AD) — From concept to clinical testing

JNHA: Clinical Trials and Aging

Analytic methods for factors, dimensions and endpoints in clinical trials for Alzheimer’s disease

JNHA: Clinical Trials and Aging

New insights into clinical trial for colostrinin™ in Alzheimer’s disease

Bridging from Clinical Endpoints to Estimates of Treatment Value for External Decision Makers

Bridging from clinical endpoints to estimates of treatment value for external decision makers
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits